A new test for anabolic drugs that can detect fast-evolving ‘designer steroids’ will be commercially trialled in racehorse drug-testing labs from October after the startup behind it, InsituGen, received $1.6 million funding from investors.
InsituGen was formed to commercialise a test
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
